When considering whether omega-3 fatty acids have any benefit for our cardiovascular system, there is an enormous amount of misinformation in the news and reputable medical journals. In this article, Mark Houston, MD and Sara Gottfried, MD review the flawed studies of meta-analyses and explain why they can lead to misinterpretation or misreporting. They then examine studies that are properly conducted by focusing on solely coronary heart disease and how they reach a different conclusions regarding omega-3 fatty acids.
Understand components and mechanisms of HDL particles, reverse cholesterol transport, and how to treat dysfunctional HDL—an overlooked cardiovascular risk. This short video walks through the idea of addressing HDL dysfunction through functional nutrition.
Beyond HDL: New Insights into HDL Cholesterol Function in Cardiovascular Disease
A major paradigm shift has emerged regarding HDL cholesterol. Strong experimental evidence suggests that HDL facilitates other cardioprotective effects in the body through various anti-inflammatory, antioxidative, antiapoptotic, anti-immune, and antithrombotic processes. On the other hand, emerging data demonstrates that total HDL cholesterol does not represent the full story. In this blog post, Mark Houston, MD and Sara Gottfried, MD outline how loss of HDL function may negatively impact cardiometabolic health.
Dyslipidemia is defined as an abnormal level of lipids in the blood and is linked with cardiovascular risk. In this article, Annalouise O’Connor, PhD, RD digs deeper into dyslipidemia, going into the details of types, testing, and treatment using targeted nutrition.
